As of 8:05:02 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
736,671.0000
770,885.0000
842,681.0000
821,682.0000
476,251.0000
Cost of Revenue
360,097.0000
408,519.0000
435,668.0000
415,335.0000
269,550.0000
Gross Profit
376,574.0000
362,366.0000
407,013.0000
406,347.0000
206,701.0000
Operating Expense
259,559.0000
299,486.0000
350,081.0000
318,557.0000
229,848.0000
Operating Income
117,015.0000
62,880.0000
56,932.0000
87,790.0000
-23,147.0000
Net Non Operating Interest Income Expense
-57,231.0000
-60,819.0000
-57,837.0000
-51,211.0000
-31,229.0000
Other Income Expense
-60,637.0000
-148,963.0000
-126,000.0000
-293,306.0000
-9,791.0000
Pretax Income
-853.0000
-146,902.0000
-126,905.0000
-256,727.0000
-64,167.0000
Tax Provision
55,207.0000
32,950.0000
88,938.0000
40,107.0000
28,604.0000
Net Income Common Stockholders
-67,431.0000
-175,522.0000
-212,047.0000
-319,597.0000
-102,157.0000
Diluted NI Available to Com Stockholders
-67,431.0000
-175,522.0000
-212,047.0000
-319,597.0000
-102,157.0000
Basic EPS
-0.18
-0.53
-0.71
-1.22
-0.49
Diluted EPS
-0.18
-0.53
-0.71
-1.22
-0.49
Basic Average Shares
343,269.9510
339,708.3080
298,161.6650
262,326.1380
210,465.9880
Diluted Average Shares
343,269.9510
339,708.3080
298,161.6650
262,326.1380
210,465.9880
Total Operating Income as Reported
114,985.0000
-87,823.0000
-84,295.0000
-217,351.0000
-23,462.0000
Rent Expense Supplemental
--
--
--
--
1,478.0000
Total Expenses
619,656.0000
708,005.0000
785,749.0000
733,892.0000
499,398.0000
Net Income from Continuing & Discontinued Operation
-67,431.0000
-175,522.0000
-212,047.0000
-319,597.0000
-102,157.0000
Normalized Income
-66,544.6200
-57,183.9500
-109,931.6000
-106,645.0500
-95,130.0200
Interest Income
2,543.0000
2,424.0000
679.0000
938.0000
1,411.0000
Interest Expense
59,774.0000
63,243.0000
58,516.0000
52,149.0000
32,640.0000
Net Interest Income
-57,231.0000
-60,819.0000
-57,837.0000
-51,211.0000
-31,229.0000
EBIT
58,921.0000
-83,659.0000
-68,389.0000
-204,578.0000
-31,527.0000
EBITDA
131,235.0000
-14,355.0000
-10,664.0000
-159,629.0000
5,228.0000
Reconciled Cost of Revenue
360,097.0000
408,519.0000
435,668.0000
415,335.0000
269,550.0000
Reconciled Depreciation
72,314.0000
69,304.0000
57,725.0000
44,949.0000
36,755.0000
Net Income from Continuing Operation Net Minority Interest
-67,431.0000
-175,522.0000
-212,047.0000
-319,597.0000
-102,157.0000
Total Unusual Items Excluding Goodwill
-1,122.0000
-149,795.0000
-129,260.0000
-291,715.0000
-9,626.0000
Total Unusual Items
-1,122.0000
-149,795.0000
-129,260.0000
-291,715.0000
-9,626.0000
Normalized EBITDA
132,357.0000
135,440.0000
118,596.0000
132,086.0000
14,854.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-235.6200
-31,456.9500
-27,144.6000
-78,763.0500
-2,599.0200
12/31/2020 - 1/25/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PSG.F PharmaSGP Holding SE
26.60
+2.31%
PSG.MU PharmaSGP Holding SE
26.60
+1.53%
CLVR Clever Leaves Holdings Inc.
0.0002
0.00%
CBSTF The Cannabist Company Holdings Inc.
0.0700
-8.14%
RMTI Rockwell Medical, Inc.
2.1300
-4.48%
LABS.TO MediPharm Labs Corp.
0.0750
0.00%
CRON Cronos Group Inc.
2.0300
+0.50%
ACB Aurora Cannabis Inc.
4.4200
-5.15%
TLRY Tilray Brands, Inc.
1.3700
-5.52%